News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Conference News CRT 2018 Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR Michael O'Riordan March 05, 2018
Presentation TCT 2017 Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure? Presenter: David H. Adams, Ted Feldman, Gilles Dreyfus October 30, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Conference News TVT 2017 Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms Shelley Wood June 15, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
Presentation TCT 2016 Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders Presenter: Jeroen J. Bax, Ileana L. Pina, Marco Moscarelli October 31, 2016
News Industry News Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure June 27, 2016
News Conference News ACC 2016 Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure Todd Neale April 05, 2016
News Daily News Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure L.A. McKeown April 19, 2013